Table 1.
Data submission per country and year
| Country | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | |||||||||||
| Cambodia | X | – | X | X | X | X | B | X | X | X | – |
| Vietnam | X | X | X | X | X | X | X | X | X | B | B |
| Laos | X | X | X | X | X | X | X | B | B | ||
| Thailand | – | X | X | – | – | X | X | – | – | B | – |
| Philippines | – | – | – | – | – | – | X | X | B | B | – |
| Indonesia | – | – | – | – | – | – | – | – | – | – | B |
| Myanmar | – | – | – | – | – | – | – | – | – | – | B |
| China (Yunnan Province) | – | – | X | – | – | – | – | – | – | – | – |
| Africa | |||||||||||
| Ghana | – | – | – | – | – | – | X | X | X | B | B |
| Kenya | – | – | – | – | – | – | – | X | B | B | – |
| Mozambique | – | – | – | – | – | – | – | – | – | X | B |
| Liberia | – | – | – | – | – | – | – | – | – | – | B |
| Ethiopia | – | – | – | – | – | – | – | – | – | X | B |
| South America | |||||||||||
| Guyana | – | – | – | – | – | X | X | X | X | – | – |
| Peru | – | – | – | – | – | X | – | X | – | – | – |
| Colombia | – | – | – | – | – | X | X | X | – | – | – |
| Ecuador | – | – | – | – | – | – | X | – | – | – | – |
B = data submitted and analyzed for this paper; however, as of July 2014, the data were not yet entered into medicines quality database (MQDB), and therefore were not publicly available.